Princess Margaret Cancer Centre

The Princess Margaret has developed a focus on the management of light-chain amyloidosis, a specific type of amyloidosis related to plasma cell dyscrasias. Our inter-professional team of pathologists, hematologists, surgeons and registered dietitians work together to monitor for amyloid deposits in body tissues. With some of the most comprehensive, cutting-edge chemotherapy, stem cell transplant and clinical research programs in Canada, our team can offer a coordinated approach to treatment that includes clinical trials.

With nearly 400 new patients every year, the Princess Margaret Myeloma Program sees the most patients with newly diagnosed or recurrent multiple myeloma in Canada.